The following discussion and analysis of the Company's financial condition and
results of operations should be read in conjunction with our audited financial
statements and the notes related thereto which are included in "Item 8.
Financial Statements and Supplementary Data" of this Annual Report on Form 10-K.
Certain information contained in the discussion and analysis set forth below
includes forward-looking statements. Our actual results may differ materially
from those anticipated in these forward-looking statements as a result of many
factors, including those set forth under "Risk Factors" appearing elsewhere in
this Form 10-K.
Overview
We are a blank check company incorporated on October 12, 2020, as a Delaware
corporation and formed for the purpose of entering into a merger, share
exchange, asset acquisition, stock purchase, recapitalization, reorganization or
similar business combination with one or more businesses or IPO and the sale of
the Private Placement Units, our capital stock, debt or a combination of cash,
stock and debt.
65
As of December 31, 2021, we had not commenced any operations. All activity for
the period from October 12, 2020 (inception) through December 31, 2021 relates
to our formation, our IPO, and identifying a target company for a business
combination. We will not generate any operating revenues until after the
completion of our initial business combination, at the earliest. We
generate non-operating income in the form of income from the proceeds derived
from the IPO. We have selected December 31 as our fiscal year end.
Our sponsor is Avalon Acquisition Holdings LLC, a Delaware limited liability
company. The registration statement for our IPO was declared effective on
October 5, 2021. On October 8, 2021, we closed the IPO and issued 20,700,000
units, which included full exercise by the underwriter of the over-allotment
option to purchase an additional 2,700,000, at $10.00 per unit, generating gross
proceeds of $207,000,000, and incurring offering costs of $10,953,007, inclusive
of $7,245,000 in deferred underwriting commissions and net of reimbursement from
underwriter of $399,202.
On October 8, 2021, simultaneously with the consummation of the IPO, we sold
8,100,000 warrants, at a price of $1.00 per private placement warrant to our
sponsor, generating proceeds of $8,100,000.
Upon the closing of the IPO and the private placement, $210,105,000 ($10.15 per
Unit) from the net proceeds of the sale of the units in the Initial Public
Offering and the sale of the Private Placement Warrants were placed in a trust
account (the "Trust Account") located in the United States with Continental
Stock Transfer & Trust Company acting as trustee, which was invested in a money
market fund meeting the conditions of Rule 2a-7 of the Investment Company Act of
1940, which invests only in direct U.S. government treasury obligations, as
determined by us, until the earlier of (i) the completion of a business
combination or (ii) the distribution of the funds in the Trust Account as
described below.
We will have until January 8, 2023 to consummate a business combination or until
July 8, 2023 if the we extend the period of time to consummate an initial
business combination by the full amount of time (the "Combination Period"). If
the we are unable to complete a business combination within the Combination
Period, we will (i) cease all operations except for the purpose of winding up,
(ii) as promptly as reasonably possible but not more than ten business days
thereafter, redeem the Public Shares, at a per-share price, payable in cash,
equal to the aggregate amount then on deposit in the Trust Account including
interest earned on the funds held in the Trust Account and not previously
released to us to pay taxes (less up to $100,000 to pay dissolution expenses),
divided by the number of then outstanding public shares, which redemption will
completely extinguish public stockholders' rights as stockholders (including the
right to receive further liquidating distributions, if any), subject to
applicable law, and (iii) as promptly as reasonably possible following such
redemption, subject to the approval of the remaining stockholders and the board
of directors, dissolve and liquidate, subject in each case to our obligations
under Delaware law to provide for claims of creditors and the requirements of
other applicable law. There will be no redemption rights or liquidating
distributions with respect to the warrants, which will expire worthless if we
fail to complete a business combination within the Combination Period.
Liquidity and Going Concern
As of December 31, 2021, we had $1,036,693 outside of the trust account and
$1,423,065 of working capital, excluding the amount of franchise tax payable.
Our liquidity needs to date have been satisfied through a payment of $25,000
from our sponsor to cover certain on our IPO in exchange for the issuance of the
founder shares, and loan proceeds from the sponsor of $197,000 under a
promissory note. We repaid the promissory note in full on October 15, 2021.
Subsequent to the closing of the IPO, our liquidity needs have been satisfied
through the net proceeds from the IPO and the private placement that are held
outside of the trust account.
66
Based on the foregoing, management believes that we will have sufficient working
capital and borrowing capacity from our sponsor or an affiliate of our sponsor
or our officers and directors to meet our needs through the earlier of the
consummation of our initial business combination or one year from the date of
this filing. Over this time period, we will be using these funds for paying
existing accounts payable, identifying and evaluating prospective initial
business combination candidates, performing due diligence on prospective target
businesses, paying for travel expenditures, selecting the target business to
merge with or acquire, and structuring, negotiating and consummating the
Business Combination.
In connection with the Company's assessment of going concern considerations in
accordance with FASB Accounting Standards Update ("ASU") 2014-15, "Disclosures
of Uncertainties about an Entity's Ability to Continue as a Going Concern,"
management has determined that the liquidation, mandatory liquidation, and
subsequent dissolution raise substantial doubt about the Company's ability to
continue as a going concern. No adjustments have been made to the carrying
amounts of assets or liabilities should the Company be required to liquidate
after the completion window. The financial statements do not include any
adjustment that might be necessary if the Company is unable to continue as a
going concern.
The outbreak of the COVID-19 coronavirus has resulted in a widespread health
crisis that has adversely affected the economies and financial markets
worldwide, and potential target companies may defer or end discussions for a
potential business combination with us whether or not COVID-19 affects their
business operations. The extent to which COVID-19 impacts our search for a
business combination will depend on future developments, which are highly
uncertain and cannot be predicted, including new information which may emerge
concerning the severity of COVID-19 and the actions to contain COVID-19 or treat
its impact, among others. We may be unable to complete a business combination if
continued concerns relating to COVID-19 restrict travel, limiting our ability to
conduct meetings to negotiate and consummate transactions in a timely manner
with potential investors, target company's personnel, or vendors and services
providers.
Results of Operations
Our entire activity since inception up to October 8, 2021 was related to our
formation and IPO. Since the IPO, our activity has been limited to the search
for a prospective initial business combination target. We will not generate any
operating revenues until the consummation of our initial business combination.
We expect to incur increased expenses as a result of being a public company (for
legal, financial reporting, accounting and auditing compliance), as well as for
due diligence expenses.
For the year ended December 31, 2021, we had net income of $3,813,684, which
consisted of $311,329 in general and administrative expenses, $124,138 in
franchise tax expense, and $479,936 of financing costs - derivative warrant
liabilities, offset by $4,725,000 gain from changes in fair value of derivative
warrant liabilities and $4,087 in investment income in the Trust Account.
For the period October 12, 2020 (inception) to December 31, 2020, we had a net
loss $1,497, which consisted solely of formation costs.
Contractual Obligations
Registration and Stockholder Rights
The holders of the Founder Shares, Private Placement Warrants and warrants that
may be issued upon conversion of Working Capital Loans (and any Class A common
stock issuable upon the exercise of the Private Placement Warrants and warrants
that may be issued upon conversion of Working Capital Loans) are entitled to
registration rights pursuant to a registration rights agreement. The holders of
these securities are entitled to make up to three demands, excluding short form
demands, that we register such securities. In addition, the holders have certain
"piggy-back" registration rights with respect to registration statements filed
subsequent to the completion of the initial Business Combination. We will bear
the expenses incurred in connection with the filing of any such registration
statements.
Underwriting Agreement
The underwriters were paid an underwriting discount of $0.125 per unit, or
$2,587,500 in the aggregate, upon the closing of our Initial Public Offering. In
addition, $0.35 per unit, or $7,245,000 in the aggregate, will be payable to the
underwriters for deferred underwriting commissions from the amounts held in the
Trust Account solely in the event that that we complete a Business Combination,
subject to the terms of the underwriting agreement.
We granted the underwriters a 45-day option from the date of our Initial Public
Offering to purchase up to 2,700,000 additional Units at the Initial Public
Offering price less the underwriting discounts and commissions. The underwriters
exercised their over-allotment option in full on October 8, 2021, generating
gross proceeds of $27 million.
67
Administrative Support Agreement
We do not have any long-term debt, capital lease obligations, operating lease
obligations or long-term liabilities, other than an agreement to pay our sponsor
a monthly fee of $10,000 for office space, administrative and support services
to the Company. We began incurring these fees on October 8, 2021 and will
continue to incur these fees monthly until the earlier of the completion of the
Business Combination and our liquidation.
Critical Accounting Estimates
Management's discussion and analysis of our financial condition and results of
operations is based on our financial statements, which have been prepared in
accordance with accounting principles generally accepted in the United States of
America. The preparation of our financial statements requires us to make
estimates and judgments that affect the reported amounts of assets, liabilities,
revenues and expenses and the disclosure of contingent assets and liabilities in
our financial statements. On an ongoing basis, we evaluate our estimates and
judgments, including those related to fair value of financial instruments and
accrued expenses. We base our estimates on historical experience, known trends
and events and various other factors that we believe to be reasonable under the
circumstances, the results of which form the basis for making judgments about
the carrying values of assets and liabilities that are not readily apparent from
other sources. Actual results may differ from these estimates under different
assumptions or conditions. We have identified the following as our critical
accounting policies:
Investments Held in Trust Account
Our portfolio of investments held in trust is comprised solely of a money market
fund that invests in U.S. government securities, within the meaning set forth in
Section 2(a)(16) of the Investment Company Act of 1940, as amended, with a
maturity of 185 days or less. Our investments held in the trust account are
classified as trading securities. Trading securities are presented on the
balance sheet at fair value at the end of each reporting period. Gains and
losses resulting from the change in fair value of these investments are included
in net gain from investments held in trust account in the accompanying
statements of operations. The estimated fair values of investments held in the
trust account are determined using available market information.
Class A Common Stock Subject to Possible Redemption
We account for our Class A common stock subject to possible redemption in
accordance with the guidance in Accounting Standards Codification ("ASC") Topic
480, "Distinguishing Liabilities from Equity." Class A common stock subject to
mandatory redemption (if any) is classified as liability instruments and are
measured at fair value. Conditionally redeemable Class A common stock (including
Class A common stock that features redemption rights that are either within the
control of the holder or subject to redemption upon the occurrence of uncertain
events not solely our control) are classified as temporary equity. At all other
times, Class A common stock is classified as stockholders' equity.
Our Class A common stock feature certain redemption rights that are considered
to be outside of our control and subject to the occurrence of uncertain future
events. Accordingly, as of the Initial Public Offering, 20,700,000 shares of
Class A common stock subject to possible redemption are presented at redemption
value as temporary equity, outside of the stockholders' deficit section of our
balance sheets. Effective with the closing of the Initial Public Offering, we
recognized the accretion from initial book value to redemption amount, which,
resulted in charges against additional paid-in capital (to the extent available)
and accumulated deficit.
Derivative Warrant Liabilities
We do not use derivative instruments to hedge exposures to cash flow, market, or
foreign currency risks. We evaluate all of our financial instruments, including
issued stock purchase warrants, to determine if such instruments are derivatives
or contain features that qualify as embedded derivatives, pursuant to ASC 480
and ASC 815-15. The classification of derivative instruments, including whether
such instruments should be recorded as liabilities or as equity, is re-assessed
at the end of each reporting period.
68
We issued 15,525,000 warrants to purchase common stock to investors in our IPO
and issued 8,100,000 private placement warrants to our sponsor. All of our
outstanding warrants are recognized as derivative liabilities in accordance
with ASC 815-40. Accordingly, we recognize the warrant instruments as
liabilities at fair value and adjust the instruments to fair value at each
reporting period. The liabilities are subject to re-measurement at each balance
sheet date until exercised, and any change in fair value is recognized in our
statements of operations. The fair value of warrants issued in connection with
the IPO and the private placement warrants was initially measured at fair value
by an independent valuation consultant using a market-based approach of
comparable blank check company warrant pricing. At December 31, 2021, the fair
value of the public warrants was based on observable closing market price for
such warrants, and value of the private warrants was fair valued based on the
pricing of the public warrants.
Off-Balance Sheet Arrangements
As of December 31, 2021, we did not have any off-balance sheet arrangements as
defined in Item 303(a)(4)(ii) of Regulation S-K.
© Edgar Online, source Glimpses